# Cartesian Therapeutics (RNAC) — Overview

RNAC · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rnac

## Price

Last close $6.58 on Oct 15, 2026. 52-week range $5.84 – $10.59.

## Company profile

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $1.5M |
| Revenue (quarter) | $0.00 |
| Revenue growth (year over year) | 0.00% |
| Gross profit (trailing twelve months) | $1.5M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$151.9M |
| Net income (quarter) | $15.8M |
| Net income growth (year over year) | -0.74% |
| Net margin | -10283.75% |
| Return on equity | 0.00% |
| EPS (trailing twelve months) | −$5.78 |
| Book value per share | −$4.17 |
| P/E (trailing twelve months) | — |
| Price to book | — |
| Debt to assets | 139.30% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Cartesian Therapeutics (RNAC) profitable?

No. Cartesian Therapeutics reported a net loss of $151.9M over the trailing twelve months.

### How much revenue does Cartesian Therapeutics (RNAC) make?

Cartesian Therapeutics generated $1.5M in revenue over the trailing twelve months.

### How do I buy stock in Cartesian Therapeutics (RNAC)?

RNAC trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).